Metastatic prostate cancer with elevated serum levels of CEA and CA19-9

Guang Dar Juang, Yi-Sheng Huang, Yuan Hung Wang

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Prostate-specific antigen (PSA) is well known as a specific tumor marker for prostate cancer, but carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-elevating adenocarcinomas originating in the prostate gland are rare. We report a case of metastatic adenocarcinoma of the prostate gland with a high serum level of CEA and CA19-9 in a 78-year-old man in whom prostate cancer (T3N1M1) had been diagnosed 2 years ago and who was treated with androgen deprivation therapy. He visited the emergency department because of a loss of appetite and abdominal pain. The serum CEA and CA19-9 levels were increased to 218.9. ng/mL (normal,

Original languageEnglish
Pages (from-to)28-30
Number of pages3
JournalUrological Science
Volume25
Issue number1
DOIs
Publication statusPublished - 2014

Fingerprint

Carcinoembryonic Antigen
Prostatic Neoplasms
Carbohydrates
Antigens
Prostate
Adenocarcinoma
Serum
Appetite
Prostate-Specific Antigen
Tumor Biomarkers
Abdominal Pain
Androgens
Hospital Emergency Service
Therapeutics

Keywords

  • Carbohydrate antigen 19-9 (CA19-9)
  • Carcinoembryonic antigen (CEA)
  • Metastatic prostate cancer
  • Tumor marker

ASJC Scopus subject areas

  • Urology

Cite this

Metastatic prostate cancer with elevated serum levels of CEA and CA19-9. / Juang, Guang Dar; Huang, Yi-Sheng; Wang, Yuan Hung.

In: Urological Science, Vol. 25, No. 1, 2014, p. 28-30.

Research output: Contribution to journalArticle

Juang, Guang Dar ; Huang, Yi-Sheng ; Wang, Yuan Hung. / Metastatic prostate cancer with elevated serum levels of CEA and CA19-9. In: Urological Science. 2014 ; Vol. 25, No. 1. pp. 28-30.
@article{d4380aaa596346ce9dbbdf0f72f4a80a,
title = "Metastatic prostate cancer with elevated serum levels of CEA and CA19-9",
abstract = "Prostate-specific antigen (PSA) is well known as a specific tumor marker for prostate cancer, but carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-elevating adenocarcinomas originating in the prostate gland are rare. We report a case of metastatic adenocarcinoma of the prostate gland with a high serum level of CEA and CA19-9 in a 78-year-old man in whom prostate cancer (T3N1M1) had been diagnosed 2 years ago and who was treated with androgen deprivation therapy. He visited the emergency department because of a loss of appetite and abdominal pain. The serum CEA and CA19-9 levels were increased to 218.9. ng/mL (normal,",
keywords = "Carbohydrate antigen 19-9 (CA19-9), Carcinoembryonic antigen (CEA), Metastatic prostate cancer, Tumor marker",
author = "Juang, {Guang Dar} and Yi-Sheng Huang and Wang, {Yuan Hung}",
year = "2014",
doi = "10.1016/j.urols.2013.05.005",
language = "English",
volume = "25",
pages = "28--30",
journal = "Urological Science",
issn = "1879-5226",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Metastatic prostate cancer with elevated serum levels of CEA and CA19-9

AU - Juang, Guang Dar

AU - Huang, Yi-Sheng

AU - Wang, Yuan Hung

PY - 2014

Y1 - 2014

N2 - Prostate-specific antigen (PSA) is well known as a specific tumor marker for prostate cancer, but carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-elevating adenocarcinomas originating in the prostate gland are rare. We report a case of metastatic adenocarcinoma of the prostate gland with a high serum level of CEA and CA19-9 in a 78-year-old man in whom prostate cancer (T3N1M1) had been diagnosed 2 years ago and who was treated with androgen deprivation therapy. He visited the emergency department because of a loss of appetite and abdominal pain. The serum CEA and CA19-9 levels were increased to 218.9. ng/mL (normal,

AB - Prostate-specific antigen (PSA) is well known as a specific tumor marker for prostate cancer, but carcinoembryonic antigen (CEA)- and carbohydrate antigen 19-9 (CA19-9)-elevating adenocarcinomas originating in the prostate gland are rare. We report a case of metastatic adenocarcinoma of the prostate gland with a high serum level of CEA and CA19-9 in a 78-year-old man in whom prostate cancer (T3N1M1) had been diagnosed 2 years ago and who was treated with androgen deprivation therapy. He visited the emergency department because of a loss of appetite and abdominal pain. The serum CEA and CA19-9 levels were increased to 218.9. ng/mL (normal,

KW - Carbohydrate antigen 19-9 (CA19-9)

KW - Carcinoembryonic antigen (CEA)

KW - Metastatic prostate cancer

KW - Tumor marker

UR - http://www.scopus.com/inward/record.url?scp=84896547234&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896547234&partnerID=8YFLogxK

U2 - 10.1016/j.urols.2013.05.005

DO - 10.1016/j.urols.2013.05.005

M3 - Article

AN - SCOPUS:84896547234

VL - 25

SP - 28

EP - 30

JO - Urological Science

JF - Urological Science

SN - 1879-5226

IS - 1

ER -